MiNK Therapeutics (INKT) EPS (Basic) (2020 - 2026)
MiNK Therapeutics (INKT) posted EPS (Basic) of -$0.58 for Q1 2026, down 1.5% sequentially from -$0.57 in Q4 2025, and up 12.2% YoY from -$0.52 in Q1 2025.
MiNK Therapeutics (INKT) EPS (Basic) (2020 - 2026) Analysis & Trends
MiNK Therapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$0.58 in Q1 2026.
- Quarterly EPS (Basic) rose 12.2% year-over-year to -$0.58 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.16 (down 21.96% YoY) and the FY2025 annual result came in at -$10.33, down 213.64% from the prior year.
- EPS (Basic) retreated to -$0.58 in Q1 2026 per INKT's latest filing, from -$0.57 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.57 in Q4 2025 and troughed at -$3.92 in Q1 2022.
- A 5-year average of -$1.9 and a median of -$1.59 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 152.57% in 2022, then surged 62.44% in 2024.
- Over 5 years, EPS (Basic) stood at -$2.35 in 2022, then soared by 32.36% to -$1.59 in 2023, then surged by 58.08% to -$0.66 in 2024, then rose by 13.75% to -$0.57 in 2025, then slipped by 1.5% to -$0.58 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.58, -$0.57, and -$2.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | MiNK Therapeutics | 60.53 Mn | 60.53 Mn | - | -0.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.49 |
| Mar 31, 2026 | -0.58 |
| Dec 31, 2025 | -0.57 |
| Sep 30, 2025 | -2.10 |
| Jun 30, 2025 | -1.36 |
| Mar 31, 2025 | -0.66 |
| Dec 31, 2024 | -0.66 |
| Sep 30, 2024 | -0.83 |
| Jun 30, 2024 | -1.38 |
| Mar 31, 2024 | -1.09 |
| Dec 31, 2023 | -1.59 |
| Sep 30, 2023 | -2.18 |
| Jun 30, 2023 | -3.14 |
| Mar 31, 2023 | -2.92 |
| Dec 31, 2022 | -2.35 |
| Sep 30, 2022 | -3.75 |
| Jun 30, 2022 | -3.26 |
| Mar 31, 2022 | -3.92 |
| Dec 31, 2021 | -2.75 |
| Sep 30, 2021 | -8.86 |